9
1
6
41.51, 138.41, 134.4, 130.34, 129.82, 128.39, 122.57, 113.79,
1.63, 55.33, 22.84, 13.63 ppm.
4.3.15 5-nitro-2-phenylpyridine (3o). White solid; m.p. 121-
ACCEPTED MANUSCRIPT
1
122 °C. H NMR (400 MHz, CDCl ): δ = 9.45 (d, J = 2.4 Hz,
3
1
H), 8.47 (dd, J = 8.8, 2.7 Hz, 1H), 8.12-8.02 (m, 2H), 7.87 (d, J
4
.3.6 Ethyl 2-(4-chlorophenyl)-4-methyl-6-phenylpyrimidine-5-
13
1
= 8.8 Hz, 1H), 7.57-7.46 (m, 3H) ppm. C NMR (100 MHz,
carboxylate (3f). White solid; m.p. 84-86 °C. H NMR (400
CDCl ): δ = 162.29, 145.16, 142.82, 136.98, 131.90, 130.88,
1
3
MHz, CDCl ): δ = 8.51-8.36 (m, 2H), 7.80-7.56 (m, 2H), 7.52-
3
29.10, 127.66, 120.00 ppm.
7
7
1
1
.29 (m, 5H), 4.13 (q, J = 7.2 Hz, 2H), 2.61 (s, 3H), 1.01 (t, J =
13
.2 Hz, 3H) ppm. C NMR (100 MHz, CDCl ): δ = 168.25,
3
65.48, 163.63, 162.64, 138.04, 137.29, 135.59, 130.00, 129.96,
28.70, 128.44, 128.41, 123.52, 61.80, 22.80, 13.64 ppm.
4
.4 General procedures for the Sonogashira coupling
reactions of pyrimidin-2-yl sulfonates with terminal alkynes
Pyrimidin-2-yl sulfonate 1 (0.25 mmol), terminal alkyne 4
(0.375 mmol), K PO (2.0 equiv.), PPh (20 mol %), 20 mg of
4
.3.7 Ethyl 4-methyl-2-(naphthalen-1-yl)-6-phenylpyrimidine-5-
1
carboxylate (3g). White solid; m.p. 83-85 °C. H NMR (400
3
4
3
MHz, CDCl ): δ = 8.62-8.60 (m, 1H), 8.06 (dd, J = 7.2, 1.2 Hz,
GO-PdCl catalyst (Pd 2.86 wt %) and CuTC (10 mol %) were
3
2
1
2
1
1
1
1
H), 7.89 (d, J = 8.2 Hz, 1H), 7.87-7.80 (m, 1H), 7.77-7.65 (m,
H), 7.59-7.31 (m, 6H), 4.18 (q, J = 7.2 Hz, 2H), 2.69 (s, 3H),
added to a Schlenk tube. The tube containing the mixture of
substrates was evacuated and purged with nitrogen gas for four
times. Then, 5 mL 1,4-dioxane was added by a syringe under
nitrogen atomosphere, and the reaction mixture was stirred at
13
.05 (t, J = 7.2 Hz, 3H) ppm. C NMR (101 MHz, CDCl ): δ =
3
68.26, 166.35, 165.29, 163.53, 137.85, 135.41, 134.05, 130.96,
30.73, 130.06, 129.58, 128.55, 128.42, 126.85, 125.85, 125.70,
25.16, 123.18, 109.69, 61.93, 22.86, 13.67 ppm.
1
10 °C for 48 h. After completion, the catalyst was separated by
centrifugation, the mixture was cooled to room temperature,
quenched by addition of saturated aqueous NH Cl (3 mL), and
4
.3.8 Ethyl 4-methyl-2-phenyl-6-p-tolylpyrimidine-5-carboxylate
1
4
(
3h). White solid; m.p. 66-67 °C. H NMR (400 MHz, CDCl ): δ
3
extracted with diethyl ether (3 × 5 mL). The organic solvents
were combined and washed with aqueous NaOH (2 mmol/mL, 2
mL), brine, and then dried with anhydrous magnesium sulfate,
filtered and concentrated under reduced pressure. The residue
was purified by silica gel column chromatography with a
mixture of ethyl acetate and petroleum ether as eluent. The
product was analyzed by GC-MS or NMR analysis. The
conversion and selectivity were determined using GC analysis.
All the prepared compounds are known and were compared with
=
8.60-8.38 (m, 2H), 7.60 (d, J = 8.1 Hz, 2H), 7.46-7.35 (m, 3H),
7
3
.23-7.17 (m, 2H), 4.16 (q, J = 7.2 Hz, 2H), 2.60 (s, 3H), 2.34 (s,
13
H), 1.06 (t, J = 7.2 Hz, 3H) ppm. C NMR (100 MHz, CDCl3):
δ = 168.63, 165.14, 163.59, 163.34, 140.23, 137.23, 135.30,
1
2
30.91, 129.17, 128.58, 128.44, 128.41, 123.14, 61.72, 22.81,
1.38, 13.73 ppm.
4
.3.9 Ethyl 4-(4-methoxyphenyl)-6-methyl-2-phenylpyrimidine-5-
1
carboxylate (3i). Colorless oil. H NMR (400 MHz, CDCl ): δ =
3
8
.54-8.43 (m, 2H), 7.77-7.62 (m, 2H), 7.45-7.36 (m, 3H), 6.88 (d,
89
J = 8.8 Hz, 2H), 4.15 (q, J = 7.2 Hz, 2H), 3.72 (s, 3H), 2.56 (s,
authentic samples.
1
3
3
H), 1.05 (t, J = 7.2 Hz, 3H) ppm. C NMR (100 MHz, CDCl3):
4
.4.1 Ethyl 4-methyl-6-phenyl-2-(phenylethynyl)pyrimidine-5-
1
δ = 168.72, 164.98, 163.36, 162.53, 161.17, 137.14, 130.82,
carboxylate (5a). White solid; m.p. 161-162 °C. H NMR (400
1
2
30.32, 130.01, 128.44, 128.36, 122.68, 113.80, 61.66, 55.24,
2.71, 13.73 ppm.
MHz, CDCl ): δ = 7.70-7.66 (m, 4H), 7.48-7.39 (m, 3H), 7.38-
3
7
.27 (m, 3H), 4.22- 4.17 (q, J = 8.0 Hz,, 2H), 2.67 (s, 3H), 1.06
13
4
.3.10 Ethyl 4-(4-fluorophenyl)-6-methyl-2-phenylpyrimidine-5-
(t, J = 8.0 Hz, 3H) ppm. C NMR (100 MHz, CDCl ) δ = 167.53,
3
1
carboxylate (3j). White solid; m.p. 85- 86 °C. H NMR (400
MHz, CDCl ): δ = 8.46 (dd, J = 6.8, 3.0 Hz, 2H), 7.77-7.62 (m,
165.59, 164.08, 152.38, 137.19, 132.85, 132.54, 130.40, 130.01,
129.91, 129.52, 128.75, 126.53, 128.38, 128.17, 124.19, 121.25,
88.53, 88.09, 61.98, 22.47, 13.48 ppm.
3
2
2
H), 7.48-7.33 (m, 3H), 7.11-7.06 (m, 2H), 4.16 (q, J = 7.2 Hz,
13
H), 2.61 (s, 3H), 1.06 (t, J = 7.2 Hz, 3H) ppm. C NMR (100
4
.4.2
Ethyl
4-Methyl-2-(oct-1-ynyl)-6-phenylpyrimidine-5-
1
MHz, CDCl ): δ = 168.33, 165.46, 165.20, 163.65, 162.71,
3
carboxylate (5b). Yellow oil. H NMR (400 MHz, CDCl3): δ =
1
1
62.28, 136.97, 134.28, 131.10, 130.58, 130.50, 128.58, 128.50,
23.16, 115.66, 115.44, 61.84, 22.82, 13.74 ppm.
7
2
.63–7.49 (m, 2H), 7.47–7.28 (m, 3 H), 4.10 (q, J = 7.2 Hz, 2 H),
.54 (s, 3 H), 2.40 (t, J = 7.3 Hz, 2 H), 1.65–1.53 (m, 2 H), 1.43–
4
.3.11 Ethyl 4-(4-chlorophenyl)-6-methyl-2-phenylpyrimidine-5-
1.33 (m, 2 H),1.28–1.19 (m, 4 H), 0.97 (t, J = 7.2 Hz, 3 H), 0.81
1
13
carboxylate (3k). White solid; m.p. 83-84 °C. H NMR (400
(t, J = 6.7 Hz, 3H) ppm. C NMR (100 MHz, CDCl3): δ =
MHz, CDCl ): δ = 8.52-8.41 (m, 2H), 7.69-7.59 (m, 2H), 7.47-
167.58, 165.39, 163.91,152.27, 137.18, 130.06, 128.44, 128.25,
123.95, 91.65, 79.93, 61.87,31.25, 28.70, 27.89, 22.52, 22.43,
19.41, 13.99, 13.53 ppm.
3
7
7
1
1
.34 (m, 5H), 4.16 (q, J = 7.2 Hz, 2H), 2.62 (s, 3H), 1.07 (t, J =
13
.2 Hz, 3H) ppm. C NMR (100 MHz, CDCl ): δ = 168.15,
3
65.55, 163.66, 162.31, 136.81, 136.56, 136.36, 131.20, 129.85,
28.73, 128.63, 128.52, 123.19, 61.92, 22.79, 13.74 ppm.
4
.4.3
Ethyl
2-(3,3-Dimethylbut-1-ynyl)-4-methyl-6-
phenylpyrimidine-5-carboxylate (5c). White solid; m.p. 98-99 °C.
1
4
.3.12 Ethyl 4-(4-bromophenyl)-6-methyl-2-phenylpyrimidine-5-
H NMR (400 MHz, CDCl ): δ = 7.57-7.36 (m, 2H), 7.46-7.25
3
1
carboxylate (3l). White solid; m.p. 87-89 °C. H NMR (400
MHz, CDCl ): δ = 8.50 (m, 2H), 7.78 (d, J = 8.4 Hz, 2H), 7.47-
7
7
1
1
(m, 3H), 4.10 (q, J = 7.2 Hz, 2H), 2.54 (s, 3H), 1.30 (s, 9H), 0.97
13
3
(t, J = 7.2 Hz, 3H) ppm. C NMR (100 MHz, CDCl ) δ = 167.61,
3
.37 (m, 5H), 4.19 (q, J = 7.2 Hz, 2H), 2.63 (s, 3H), 1.06 (t, J =
165.29, 163.90, 152.51, 137.33, 129.99, 128.43, 128.29, 123.94,
98.45, 78.87, 61.82, 30.38, 27.90, 22.52, 13.54. ppm.
13
.2 Hz, 3H) ppm. C NMR (100 MHz, CDCl ): δ = 168.52,
3
65.39, 163.06, 137.14, 137.00, 131.02, 128.94, 128.87, 128.60,
28.49, 127.78, 127.18, 127.16, 123.22, 61.82, 22.88, 13.72 ppm.
4
.4.4 Ethyl 4-Methyl-6-phenyl-2-(p-tolylethynyl)pyrimidine-5-
1
carboxylate (5d). Yellow oil. H NMR (400 MHz, CDCl ): δ =
3
4
.3.13 Methyl 4-methyl-2,6-diphenylpyrimidine-5-carboxylate
7.65-7.56 (m, 2H), 7.51 (d, J = 8.0 Hz, 2H), 7.45-7.33 (m, 3H),
7.10 (d, J = 7.9 Hz, 2H), 4.12 (q, J = 7.2 Hz,, 2H), 2.58 (s, 3H),
o
1
(
3m). White solid; m.p. 123-125 C. H NMR (400 MHz, CDCl ):
3
13
δ = 8.57-8.55 (m, 2H), 7.77-7.76 (m, 2H), 7.51-7.48 (m, 6H),
2.30 (s, 3H), 0.99 (t, J = 7.2 Hz, 3H) ppm. C NMR (100 MHz,
13
3
1
1
.72 (s, 3H), 2.68 ppm (s, 3H). C NMR (100 MHz, CDCl ): δ =
CDCl ) δ = 167.57, 165.54, 164.05, 152.47, 140.17, 137.20,
3
3
69.03, 165.46, 163.77, 163.40, 138.10, 137.10, 131.06, 130.07,
28.63, 128.54, 128.49, 128.35, 123.00, 52.53, 22.89 ppm.
132.65, 130.16, 129.13, 128.54, 128.29, 124.00, 118.09, 89.07,
87.66, 61.96, 22.61, 21.63, 13.58 ppm.
1
4
.3.14 2-Phenylpyridine (3n). Colorless oil. H NMR (400 MHz,
4.4.5
Ethyl
4-Methyl-2-(oct-1-ynyl)-6-p-tolylpyrimidine-5-
1
CDCl ): δ = 8.62 (d, J = 4.6 Hz, 1H), 7.97-7.87 (m, 2H), 7.73-
.59 (m, 2H), 7.42-7.32 (m, 3H), 7.24-7.12 (m, 1H) ppm.
NMR (100 MHz, CDCl ): δ = 157.33, 149.50, 139.17, 136.85,
28.97, 128.72, 126.88, 122.08, 120.59 ppm.
carboxylate (5e). Yellow oil. H NMR (400 MHz, CDCl ): δ =
3
3
13
7
C
7.48 (dd, J = 8.2, 2.0 Hz, 2 H), 7.18–7.14 (m, 2H), 4.13 (dd, J =
7.2, 2.9 Hz, 2H), 2.52 (d, J = 2.5 Hz, 3 H), 2.42–2.37 (m, 2H),
2.31 (d, J = 2.6 Hz, 3H), 1.64–1.54 (m, 2 H), 1.38 (dd, J = 13.1,
3
1